How can the antimicrobial resistance community leverage lessons learned from COVID-19 to highlight the importance of having effective antibiotic treatments available in the future? Join Ed Silverman, Pharmalot columnist, senior writer, Stat News, Maryn McKenna, journalist, author of Big Chicken, senior fellow, Emory University, columnist, WIRED, Manos Perros, president and chief executive officer, Entasis Therapeutic, Ted Schroeder, chief executive officer, Nabriva Therapeutics, and Evan Loh, chief executive officer, Paratek Pharmaceuticals, who will discuss the current scientific understanding of COVID-19’s impact on resistance, antibiotic marketplace and status of U.S. legislation, preparedness and implications for future outbreaks and U.S.-based manufacturing and supply chain for antibiotics.